Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Celgene successfully completes phase I multiple-dose trial of lead SelCID compound

Sep. 14, 1998

Role of oral porcine spasmolytic polypeptide in GI disorders studied by Danish group

Sep. 14, 1998

Antisense oligodeoxynucleotide to rat ICAM-1 tested in rat model of enterocolitis

Sep. 14, 1998

Preclinical and clinical data support potential of MKC-733 in GI motor disorders

Sep. 11, 1998

Early clinical results reported for osutidine, an H2 antagonist from Toyama

Sep. 10, 1998

Antisecretory and antiulcer effects of S-0509 characterized in rats

Sep. 10, 1998

KW-5139 effective for reducing gastric stasis following pancreatoduodenectomy

Sep. 10, 1998

FDA grants fast track status for CDP-571

Sep. 10, 1998

Allelix GI drug moves into the clinic

Sep. 10, 1998

Positive clinical trial results reported for HTF-919

Sep. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...